The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy-Reference-Cited by-同舟云学术

The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy

Published:2021-12 Issue: Volume:26 Page:1466-1478
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Cui Zifeng,Liu Hui,Zhang Hongfeng,Huang Zhaoyue,Tian Rui,Li Lifang,Fan Weiwen,Chen Yili,Chen Lijie,Zhang Sen,Das Bhudev C.,Severinov Konstantin,Hitzeroth Inga Isabel,Debata Priya Ranjan,Jin Zhuang,Liu Jiashuo,Huang Zheying,Xie Weiling,Xie Hongxian,Lang Bin,Ma Ji,Weng Haiyan,Tian Xun,Hu Zheng^ORCID

Funder

National Major Science and Technology Projects of China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference48 articles.

1. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9;Gupta;J. Clin. Invest.,2014

2. CRISPR/Cas9 for cancer research and therapy;Zhan;Semin. Cancer Biol.,2019

3. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer;Provasi;Nat. Med.,2012

4. TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer;Nyquist;Proc. Natl. Acad. Sci. USA,2013

5. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases;Perez;Nat. Biotechnol.,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal and cellular therapeutic approaches for Down syndrome: A research update;Biochemical and Biophysical Research Communications;2024-11

2. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review;Frontiers in Oncology;2024-06-07

3. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-05

4. Application and progress of CRISPR/Cas9 gene editing in B-cell lymphoma: a narrative review;Translational Cancer Research;2024-03

5. Undetectable off-target effects induced by FokI catalytic domain in mouse embryos;Genome Biology;2024-02-20